Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 8/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.36 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | UBE2N | P61088 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7184588 | 0.86 | GAA (0.41) | HTR6HKDC1 | |
| SCHEMBL7198914 | 0.83 | LDHA (0.53) | HTR6CYP2D6HKDC1 | |
| SCHEMBL7195706 | 0.82 | MEN1 (0.43) | HTR6KDM4EALDH1A1TSHR | |
| SCHEMBL7195905 | 0.79 | HTR6 (0.40) | HTR6ALDH1A1CYP2D6CYP2A6 | |
| SCHEMBL7203750 | 0.79 | HTR6 (0.66) | HTR6CYP2D6 | |
| SCHEMBL3953419 | 0.75 | HTR6 (0.37) | HTR6KDM4EALDH1A1CYP2D6CYP2A6 | |
| SCHEMBL7197731 | 0.74 | L3MBTL1 (0.49) | KDM4E | |
| SCHEMBL7540797 | 0.74 | ALDH1A1 (0.40) | KDM4EALDH1A1CYP2A6UBE2NTSHR | |
| SCHEMBL7184712 | 0.74 | TTR (0.47) | KDM4EALDH1A1CYP2A6HKDC1 | |
| SCHEMBL2653843 | 0.74 | LDHA (0.58) | KDM4ECYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020094993-A1 | Compositions for repelling crawling insects | S.C. JOHNSON & SON, INC. | 2002-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020094993-A1 | Compositions for repelling crawling insects | ACHE, DDT, GAP43 | HTR6 2178/4885KDM4E 3406/4885ALDH1A1 1488/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.